New $1 billion fund aims to steer antibiotic companies in a tough market
July 09, 2020 at 09:15 AM EDT
A new $1 billion fund backed by 20 drugmakers including Eli Lilly, Merck and Pfizer is aiming to bolster struggling antibiotic companies and sustain a pipeline for new treatments, an industry group said on Thursday.
